Atlas Trials

Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection

Clinical trial NCT04345276 · COMPLETED

Trial details

NCT number
NCT04345276
Sponsor
Huoshenshan Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19
Start date
2020-03-18
Primary completion
2020-04-15
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.